[Federal Register Volume 60, Number 178 (Thursday, September 14, 1995)]
[Notices]
[Page 47753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-22895]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Heart, Lung, and Blood Institute; Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart, Lung, and Blood Special Emphasis Panel (SEP) meetings:

    Name of SEP: Collection and Storage Centers for Clinical 
Research on Transplantation of Umbilical Cord Stem and Progenitor 
Cells.
    Date: October 30, 1995.
    Time: 8:00 a.m.
    Place: Holiday Inn, Bethesda, Maryland.
    Contact Person: Deborah P. Beebe, Ph.D., Rockledge II, Room 
7206, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0303.
    Purpose/Agenda: To review and evaluate contract proposals.

    Name of SEP: Transplant Centers for Clinical Research on 
Transplantation of Umbilical Cord Stem and Progenitor Cells.
    Date: October 30-31, 1995.
    Time: 3:00 p.m.
    Place: Holiday Inn, Bethesda, Maryland.
    Contact Person: Deborah P. Beebe, Ph.D., Rockledge II, Room 
7206, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0303.
    Purpose/Agenda: To review and evaluate contract proposals.

    Name of SEP: Medical Coordinating Center for Clinical Research 
on Transplantation of Umbilical Cord Stem and Progenitor Cells.
    Date: October 31, 1995.
    Time: 10:00 a.m.
    Place: Holiday Inn, Bethesda, Maryland.
    Contact Person: Deborah P. Beebe, Ph.D., Rockledge II, Room 
7206, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0303.
    Purpose/Agenda: To review and evaluate contract proposals.

    These meetings will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the applications 
and/or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: September 8, 1995.
Susan K. Feldman,
Committee Management Officer, National Institutes of Health.
[FR Doc. 95-22895 Filed 9-13-95; 8:45 am]
BILLING CODE 4140-01-M